Better Therapeutics announced today that it expects its merger with Mountain Crest Acquisition Corp to close next month. San Francisco-based Better Therapeutics announced its intention to merge with Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), in April. At the time of the announcement, the companies expected the merger to be completed some time […]
Better Therapeutics
Better Therapeutics secures $50M debt facility for digital diabetes treatment tech
Better Therapeutics announced today that it secured a loan debt facility worth up to $50 million from Hercules Capital. The debt facility provides up to $150 million in total financing when combined with the proceeds from going public through a $113 million merger with SPAC Mountain Crest Acquisition Corp II and a PIPE investment. According […]
Better Therapeutics initiates real-world study for digital therapeutic for diabetes
Better Therapeutics announced today that it commenced a real-world evidence study to evaluate its treatment for Type 2 diabetes. Collaborating with Steward Health Care, Better Therapeutics is evaluating BT-001, an investigational, prescription digital therapeutic (PDT) designed to deliver a novel form of cognitive-behavioral therapy to patients with uncontrolled Type 2 diabetes, according to a news […]
Better Therapeutics to go public via $113M merger with SPAC
Better Therapeutics announced today that it will go public through a $113 million merger with Mountain Crest Acquisition Corp II Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), will acquire Better Therapeutics in a deal expected to be completed in the summer of this year, with the company continuing to operate as Better Therapeutics […]
